🇨🇦 Randomisation to mepolizumab in Canada

Randomisation to mepolizumab (Randomisation to mepolizumab) regulatory status in Canada.

Marketing authorisation

Randomisation to mepolizumab in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Randomisation to mepolizumab approved in Canada?

Yes. Health Canada has authorised it.

Who is the marketing authorisation holder for Randomisation to mepolizumab in Canada?

Cliniques universitaires Saint-Luc- Université Catholique de Louvain is the originator. The local marketing authorisation holder may differ — check the official source linked above.